TWIST1 plays a pleiotropic role in determining the anaplastic thyroid cancer phenotype.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 21389145.
- Also identified by DOI 10.1210/jc.2010-1182.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anaplastic thyroid carcinoma (ATC) is one of the most aggressive human tumors; it is characterized by chemoresistance, local invasion, and distant metastases. ATC is invariably fatal. The aim was to study the role of TWIST1, a basic helix-loop-helix transcription factor, in ATC. Expression of TWIST1 was studied by immunohistochemistry and real-time PCR in normal thyroids and well-differentiated, poorly differentiated, and ATC. The function of TWIST1 was studied by RNA interference in ATC cells and by ectopic expression in well-differentiated thyroid carcinoma cells. ATCs up-regulate TWIST1 with respect to normal thyroids as well as to poorly and well-differentiated thyroid carcinomas. Knockdown of TWIST1 by RNA interference in ATC cells reduced cell migration and invasion and increased sensitivity to apoptosis. The ectopic expression of TWIST1 in thyroid cells induced resistance to apoptosis and increased cell migration and invasion. TWIST1 plays a key role in determining malignant features of the anaplastic phenotype in vitro.
Medical subject headings
- Carcinoma
- Nuclear Proteins
- Thyroid Neoplasms
- Twist-Related Protein 1